PMV Pharmaceuticals adds veteran investor Dr. Eckler to its board, bringing over 20 years of expertise from firms like Samsara BioCapital and GMT Capital to the company's governance structure.
Appointment of an experienced healthcare investor to the board is a routine governance event with minimal expected impact on the stock.
PMV Pharmaceuticals has appointed Dr. Eckler to its board of directors, leveraging his two decades of experience in public and private healthcare investing. The move adds strategic oversight from a veteran of firms including Samsara BioCapital and ArrowMark.
Dr. Eckler, a healthcare investor with over two decades of experience across public and private markets, has been appointed to the board.